Related Experiment Video
Updated: Jun 7, 2026
03:26
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
Botulinum toxin a for idiopathic detrusor overactivity
Kwok Ying Lie1, Michael Y C Wong, Lay Guat Ng
1Department of Urology, Singapore General Hospital, Singapore.
Annals of the Academy of Medicine, Singapore
|October 20, 2010
Summary
Botulinum toxin type A (BTX-A) effectively treats idiopathic detrusor overactivity (IDO), improving overactive bladder (OAB) symptoms like incontinence and quality of life. This treatment offers a valuable option for managing OAB.
Area of Science:
- Urology
- Pharmacology
Background:
- Idiopathic detrusor overactivity (IDO) causes bothersome overactive bladder (OAB) symptoms.
- Botulinum toxin type A (BTX-A) is an emerging treatment for OAB.
- This study evaluates BTX-A efficacy in IDO patients.
Purpose of the Study:
- To assess the effectiveness of BTX-A injections for treating idiopathic detrusor overactivity (IDO).
- To evaluate changes in patient-reported outcomes and urodynamic parameters following BTX-A treatment for OAB.
Main Methods:
- Nineteen patients with IDO received 200 units of BTX-A via intradetrusor injection.
- Subjective outcomes (IPSS, QOL, voiding diary) and urodynamics were assessed pre- and post-treatment.
- Follow-up occurred at 6 weeks, 3, 6, and 9 months, with urodynamics between 6 weeks and 3 months.
Main Results:
- Significant improvements were observed in quality of life, incontinence episodes, functional capacity, and voiding intervals at 3 months (P < 0.05).
- Urodynamic studies showed increased reflex volume and decreased maximal detrusor pressure and leak volume.
- BTX-A demonstrated potentially greater efficacy in female patients, with manageable side effects.
Conclusions:
- Botulinum toxin type A (BTX-A) is a well-tolerated and effective treatment for idiopathic detrusor overactivity (IDO).
- BTX-A significantly improves OAB symptoms and urodynamic parameters.
- It represents a valuable addition to the therapeutic options for IDO.
More Related Videos
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:26The Micturition Reflex
Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...